S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
Ad PulseStocks
Mr Wonderful's DeFi Winner
Kevin O'Leary picks one stock from each sector. This is his pick for DeFi.

MarketBeat | Stock Market News and Research Tools

Free Email Newsletter

Sign up to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Sector Performance

Sector Performance MapSector Performance Map
Ad ProTrading Research
Disruptor Stocks…
You could be just one stock away from a huge win… People did it with Amazon, Uber, Apple, and many other disruptor stocks. And this company offers a massive market, significant growth, and a huge opportunity for everyday investors…

Popular Stocks

CompanyCurrent PricePrice Change
Apple Inc.
Microsoft Co.
Meta Platforms Inc.
Alphabet Inc.
Amazon.com, Inc.
Tesla, Inc.
Alibaba Group Holding Limited
Nio Inc -
Advanced Micro Devices, Inc.
Canopy Growth Co.
Micron Technology, Inc.
General Electric
Follow Stocks

Analyst Ratings

salesforce.com, inc.
JPMorgan Chase & Co.Set Price Target
Apple Inc.
JPMorgan Chase & Co.Set Price Target
Intel Co.
Sanford C. BernsteinSet Price Target
The Boeing Company
UBS GroupSet Price Target
Intel Co.
BarclaysSet Price Target
Tesla, Inc.
BarclaysSet Price Target
Seagate Technology Holdings plc
WedbushBoost Price Target
$90.00 ➝ $95.00
United Rentals, Inc.
The Goldman Sachs GroupBoost Price Target
$415.00 ➝ $425.00
Hudson Pacific Properties, Inc.
The Goldman Sachs GroupLower Price Target
$32.00 ➝ $28.00
Eagle Materials Inc.
The Goldman Sachs GroupBoost Price Target
$181.00 ➝ $190.00
Rockwell Automation, Inc.
The Goldman Sachs GroupLower Price Target
$326.00 ➝ $294.00
Landstar System, Inc.
The Goldman Sachs GroupLower Price Target
$167.00 ➝ $155.00
See All Analyst Ratings


This Emerging Biotech Company is Working to Create Shareholder Value!


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
Ad ProTrading Research
Our #1 Health Stock
Some of the biggest, smartest, most informed investors on Wall Street are flocking to invest in this Top Health Stock w/ FDA approval. You may only get one opportunity in life to invest in something this big this early… This stock could shoot up to 5, 10, 20, even 50 times its value.
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.